definiens: , or means all operations in the manufacturing, production, packaging, labeling, war ehousing, quality control testing ( including in - process release and stability testing, when applicable ) and release of Bulk CCM or, where the context requires, Exosomes . ” -6- Confidential b. Section 2.6.2 of the Supply Agreement shall be a mended and restated in its entirety to read as follows : “ 2.6.2 [COMPANY] shall provide Suneva with such assi stance as may be reasonably requested by Suneva so as to enable a ma nufacturing facility designated by Suneva to Manufacture CCM and Exosomes . Such ass istance will include, without limitation : ( i ) permitting Suneva and its r epresentatives to observe the Manufacture of Bulk CCM and Exosomes at the Facilit y ( subject to the terms and conditions of Section 2.3(a ) ), ( ii ) providing reaso nable access to and consultation with persons knowledgeable of the Manufacture of th e Bulk CCM and Exosomes, ( iii ) providing access to relevant technical inform ation, and ( iv ) providing reasonable assistance to Suneva in identifying, contacting and securing supply sources for Bulk CCM excipients and Exosome excipients, if applicabl e. If such assistance is provided following the termination of this Agreement, Suneva shall reimburse [COMPANY] only for its out - of - pocket costs in connection with esta blishing an adequate Alternative Manufacturing Facility . ” 8 . Technology Support . [COMPANY] acknowledges that A llergan has designated its manufacturing facility i n Houston, Texas as an Alternative Manufacturing Faci lity for purposes of Section 2.6 of the Supply Agreement . [COMPANY] confirms its obligations under Section 2.6 of the Supply Agreement shall survive a ny expiration or other termination of the Supply Agree ment and shall continue until December 31, 2025